Bacteriophages as New previously overlooked Human Viral Pathogens
Bacteriophages are previously overlooked triggers of neurodegeneration and autoimmunity
Implying bacteriophages as novel therapeutic targets to breakthrough neurodegeneration and autoimmunity
By highlighting bacteriophages as novel therapeutic targets for the discovery and development of medical products, TETZ LABORATORIES has established a unique pipeline of drug candidates for neurodegenerative and autoimmune pathologies.
TETZ LABORATORIES is a pioneering microbiome company employing various proprietary technologies to develop breakthrough therapeutics and diagnostic tools.
Tetz Laboratories is conducting cutting-edge microbiome research fueled by a one-of-a-kind scientific team with a broad multidisciplinary approach.
Our latest discoveries provide us with the ability to rethink how we treat and prevent neurodegenerative and autoimmune diseases and to bring their therapy to a new level of efficacy based on our discovery of bacteriophages as new human viral pathogens and novel therapeutic targets